About
Neurix develops human iPSC-based in vitro cellular and organoid models for drug discovery and neurotherapeutic research. It serves researchers working on brain diseases and preclinical compound testing from Geneva, Switzerland.
Services
Glioblastoma Invasion Model
Glioblastoma-organoid assembloids used to assess drug efficiency on tumour growth, motility, and metastasis, and to test effects on healthy tissue using organoids.
Blood-Brain Barrier Model
Transwell-based model seeded with iPSC-derived human brain microvascular endothelial cells to assess compound penetration efficiency.
Alzheimer's Disease Model
Human organoid model with disease-specific readouts including morphology, protein aggregation, and beta-amyloid immunoreactivity.
Parkinson's Disease Model
Human organoid model with disease-specific readouts including morphology, protein and alpha-synuclein aggregation.
Personalised Service
Custom neural tissues from human stem cells, with bespoke disease models, assays, and in-depth omics analyses for drug discovery.
High throughput drug screening
A personalised-service assay for screening compounds at higher throughput.
Lead compound validation
A personalised-service method for validating lead compounds.
iPSCs differentiation
Differentiation of induced pluripotent stem cells for personalised neural model development.
7 more services
- Spheroid generation
- 2D/3D imaging
- 3D imaging
- Immunohistochemistry/Immunofluorescence
- Fluorescence-based assays
- Flow cytometry
- Genomics, Proteomics
Capabilities
- Assays and studies
- Flow cytometry
- Compound screening
- Drug efficiency testing
- Compound penetration testing
- Morphology readouts
- Protein aggregation readouts
12 more
- Alpha-synuclein aggregation
- High throughput drug screening
- Lead compound validation
- 2D imaging
- 3D imaging
- Immunohistochemistry
- Immunofluorescence
- Genomics
- Proteomics
- Drug screening
- Compound testing
- Fluorescence-based assays
- Scale and capacity
- High throughput
- Short-term compound testing
- Long-term compound testing
- Highly physiological human 3-dimensional tissues
- Therapeutic areas
- Glioblastoma
- Blood-brain barrier
- Alzheimer's disease
- Parkinson's disease
- Neurodegenerative diseases
- Brain disorders
3 more
- Neuroscience
- Neurotherapeutic research
- Neuro-oncology
Instruments and platforms
- Flow cytometry
Modalities and species
- Modalities
- Cell therapy
- Species and models
- Human iPSCs
- Human brain microvascular endothelial cells
- iPSCs-derived neurons
- Astrocytes
- Oligodendrocytes
- BMEC
5 more
- Cell line-derived spheroids
- Patient-derived spheroids
- Human
- iPSC-derived human brain microvascular endothelial cells
- Cell line or patient-derived spheroids
Industries served
- Biotechnology
- Pharmaceuticals
- Neuroscience
- Drug discovery
Details
- Founded
- 2011
- Based in
- Geneva, Switzerland
- Serves
- Worldwide, Europe
- Phone
- +41 22 379 46 43